Key result
Globorisk model estimates ~14% average 10-year CVD risk among Malaysian adults with substantial regional variation.
Why the study?
The study aimed to apply the Globorisk model to estimate overall, sex-, ethnic-, region-, and state-specific 10-year CVD risk among Malaysian adults.
What is the 10-year risk for cardiovascular disease among Malaysian adults using the Globorisk prediction model?
Cross-Sectional (n=8,253)
Yes
What is the 10-year risk for cardiovascular disease among Malaysian adults using the Globorisk prediction model?
The Globorisk model reveals substantial sex-, ethnicity-, and state-specific differences in the 10-year risk of cardiovascular disease among Malaysian adults.
Supports targeted CVD prevention planning in Malaysia; extends Globorisk use in Asia but leaves open prospective validation.
Background and Objectives: Globorisk is a well-validated risk prediction model that predicts cardiovascular disease (CVD) in the national population of all countries. We aim to apply the Globorisk calculator and provide the overall, sex-specific, ethnic-specific, region-specific, and state-specific 10-year risk for CVD among Malaysian adults. Materials and Methods: Using Malaysia’s risk factor levels and CVD event rates, we calculated the laboratory-based and office-based risk scores to predict the 10-year risk for fatal CVD and fatal plus non-fatal CVD for the Malaysian adult population. We analysed data from 8253 participants from the 2015 nationwide Malaysian National Health and Morbidity Survey (NHMS 2015). The average risk for the 10-year fatal and fatal plus non-fatal CVD was calculated, and participants were further grouped into four categories: low risk (<10% risk for CVD), high risk A (≥10%), high risk B (≥20%), and high risk C (≥30%). Results: Results were reported for all participants and were then stratified by sex, ethnicity, region, and state. The average risks for laboratory-based fatal CVD, laboratory-based fatal plus non-fatal CVD, and office-based fatal plus non-fatal CVD were 0.07 (SD = 0.10), 0.14 (SD = 0.12), and 0.11 (SD = 0.09), respectively. Conclusions: There were substantial differences in terms of the sex-, ethnicity- and state-specific Globorisk risk scores obtained.
No takes yet. Share an insight, caveat, or question.
Nawi et al. (2022) conducted a cross-sectional in Cardiovascular disease (n=8,253). Globorisk prediction model was evaluated on 10-year risk for fatal CVD and fatal plus non-fatal CVD. The Globorisk model estimated the average 10-year risk for laboratory-based fatal plus non-fatal CVD at 0.14 (SD=0.12) among Malaysian adults, with substantial demographic and regional differences.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: